Related Experiment Video
Updated: Jan 19, 2026
06:30
Author Spotlight: Purifying High-Quality Tubulin to Study Protein Dynamics and Therapeutic Applications
Published on: October 11, 2024
2.3K
Tubulin-binding drug screening by MALDI-TOFMS.
Paul Hannewald1, Benoît Maunit, Jean-François Muller
1Laboratoire de Spectrométrie de Masse et de Chimie Laser, 1, Boulevard Arago, F-57078 METZ Technopôle 2000 Cedex 03, France.
Analytical Chemistry
|July 1, 2006
Summary
Researchers developed a new test to screen compounds for binding to tubulin, a key cancer target. This method offers accurate and reproducible results for discovering novel anti-cancer drugs.
Area of Science:
- Oncology
- Biochemistry
- Analytical Chemistry
Background:
- Current cancer drugs have limitations in tolerance and side effects.
- Tubulin is a validated and promising target for chemotherapeutic agents.
- Novel compounds targeting tubulin could enhance existing cancer treatment options.
Purpose of the Study:
- To introduce a novel screening assay for evaluating compound-tubulin interactions.
- To establish a reliable method for identifying potential anti-cancer drug candidates.
Main Methods:
- Development of a screening protocol incorporating three distinct sampling strategies.
- Utilizing Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry (MALDI-TOFMS) for analysis.
- Validation of the assay's specificity by assessing unspecific binding.
Main Results:
- The developed screening protocol demonstrated high accuracy and reproducibility.
- The three sampling strategies proved effective for tubulin binding analysis.
- The test confirmed specificity, showing no loss due to unspecific binding.
Conclusions:
- The novel screening protocol is a valuable tool for identifying compounds that bind to tubulin.
- This assay can aid in the discovery of new chemotherapeutic agents.
- The method meets essential criteria for effective screening in drug development programs.
Related Concept Videos
06:30Optimizing Tubulin Yield from Porcine Brain Tissue
2.3K
This protocol describes a technique for the high-yield isolation of tubulin from the porcine brain optimized for small-scale instrumentation. The isolation procedures are complemented by procedures for determining tubulin polymerization activity in vitro using co-sedimentation assays and transmission electron...
2.3K
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
454
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
454
01:24Tissue-Drug Binding: Localization of Drugs and its Significance
399
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
399
01:23Factors Affecting Protein-Drug Binding: Drug Interactions
564
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
564
01:30Drug Binding to Blood Components
509
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
509
01:21Drug Distribution: Tissue Binding
3.8K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
3.8K